This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Berg KD, Brinster NK, Huhn KM, Goggins MG, Jones RJ, Makary A et al. Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation. N Engl J Med 2001; 345: 1458–1463.
Niederwieser DW, Appelbaum FR, Gastl G, Gersdorf E, Meister B, Geissler D et al. Inadvertent transmission of a donor′s acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia. N Engl J Med 1990; 322: 1794–1796.
Hertenstein B, Hambach L, Bacigalupo A, Schmitz N, McCann S, Slavin S et al. Development of leukemia in donor cells after allogeneic stem cell transplantation—a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2005; 90: 969–975.
Reichard KK, Zhang QY, Sanchez L, Hozier J, Viswanatha D, Foucar K . Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature. Am J Hematol 2006; 81: 178–185.
Ross DM, Jackson SR, Browett PJ . Philadelphia-negative secondary acute myeloid leukaemia during imatinib treatment for chronic phase chronic myeloid leukaemia. Leuk Lymphoma 2007; 48: 1231–1233.
Alimena G, Breccia M, Mancini M, Ferranti G, De Felice L, Gallucci C et al. Clonal evolution in Philadelphia chromosome negative cells following successful treatment with Imatinib of a CML patient: clinical and biological features of a myelodysplastic syndrome. Leukemia 2004; 18: 361–362.
Chen J, Schmitt A, Giannopoulos K, Chen B, Rojewski M, Döhner H et al. Imatinib impairs the proliferation and function of CD4+CD25+ regulatory T cells in a dose-dependent manner. Int J Oncol 2007; 31: 1133–1139.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ditschkowski, M., Haferlach, C., Schulte, C. et al. Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT. Bone Marrow Transplant 44, 265–266 (2009). https://doi.org/10.1038/bmt.2009.8
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.8